People in the U.S. die the youngest and experience the most avoidable deaths, despite spending much more on health care.
Breastfeeding through the first year of infants' lives can lower their risk of asthma by colonizing their bodies with a ...
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
Black women are more likely than white women to die from even the most treatable types of breast cancer, a study published ...
New research shows about one in eight of all cancer cases are linked to common infections like HPV, Hepatitis B and C and H. pylori. NBC News medical contributor Dr. Natalie Azar joins TODAY to share ...
Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...
Los Angeles health officials announced they are investigating a handful of locally acquired dengue fever cases in the city of ...
Novartis’ Kisqali receives US FDA approval to reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Thursday, September 19, 2024, 13:00 Hrs [IST] Novarti ...
Women with early-stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the ...
Prescribed medications like Ozempic and Wegovy can be expensive and hard to find, leading to a rise in popularity of natural ...